SSF Clinical Practice Guideline's

Overview

In 2009, the Sjögren’s Syndrome Foundation launched an initiative to develop Clinical Practice Guidelines for Sjögren’s, which aim to:

  1. Improve the quality of care for Sjögren’s patients by developing guidelines for the assessment and management of a variety of disease manifestations.
  2. Create documents to delineate Sjögren’s guidelines for U.S. clinicians.
  3. Obtain broad acceptance of guidelines from key stakeholders, including professional organizations and government agencies.

Phase 1

Completed in 2015, Phase 1 of this initiative resulted in the development of the first U.S. guidelines for the management and treatment of systemic and ocular manifestations of Sjögren’s as well as guidance for caries prevention in Sjögren’s.

View and download the guidelines created through Phase 1 below:

The SSF thanks all who contributed to the creation of the Phase 1 guidelines. A full list of contributors is available online.

Phase 2

The second phase of this initiative will significantly increase the guidance offered on the management and treatment of Sjögren’s. The following topics will be addressed in Phase 2:

Systemic Manifestations in Sjögren’s
(Pumonary; Peripheral nervous system (PNS); Central nervous system (CNS); Lymphoma and other blood cancers; Vasculitis)

Oral Manifestations in Sjögren’s
(Muscosal management and symptom relief; Use of secretagogues; Caries management and restoration)

Ocular Manifestations in Sjögren’s
(Update and expand on the ocular guidelines developed in Phase 1 and TFOS DEWS II Report)

Cross-cutting Topics
(Parotid and lacrimal gland swelling)

 Developing Guidelines

The SSF consulted with other professional organizations, including the American College of Rheumatology, American Dental Association, American Academy of Neurology, consultants from the American Society of Clinical Oncology and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology system to devise a transparent and rigorous guidelines development process. This process informed all aspects of guideline development, which includes drafting clinical questions, pre-selecting parameters for acceptable studies, literature searches, data extraction and using a Delphi-type approach to gain consensus for recommendations. For consensus, the SSF created Consensus Expert Panels, comprised of at least 30 professional experts and patients, who reviewed, voted and provided input on recommendations. A minimum of 75% consensus is needed in this step of the process.